Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.619 USD | +0.72% | +8.28% | +13.18% |
May. 09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.18% | 128M | |
+8.21% | 115B | |
+12.94% | 107B | |
-13.61% | 22.31B | |
-3.99% | 21.6B | |
-5.79% | 18.23B | |
-39.93% | 17.62B | |
+7.30% | 14.26B | |
+33.59% | 12.37B | |
-28.05% | 8.28B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wells Fargo Downgrades Sangamo Therapeutics to Equal-Weight From Overweight, Price Target is $1